Bristol-Myers Squibb-Bristol Myers buys Orbital Therapeutics for $1.5 billion

Bristol Myers buys Orbital Therapeutics for $1.5 billion

百时美施贵宝(US:BMY) Reuters·2025-10-10 19:05

Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash. ...